# Panama Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Panama HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Panama (PAN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $61.3M
- Products: 24
- Buyer markets: 27
- Average CAGR: +37.9%
- Global sector size: $586.1B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $313.2B | $15.4M | $117.6B | +1.6% | 23 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $97.4B | $1.7M | $37.4B | +88.4% | 6 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $21.5B | $417.4K | $15.3B | +248.0% | 9 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $24.4B | $102.9K | $14.4B | -7.0% | 7 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.8B | $62.7K | $9.6B | +10.2% | 2 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $17.6B | $1.3M | $9.0B | -14.0% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $1.7M | $8.8B | +8.2% | 5 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $12.8B | $3.2M | $8.6B | -10.5% | 2 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $8.3B | $3.9M | $8.5B | -6.1% | 1 | +0.1% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $8.7B | $12.1K | $6.2B | +83.3% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $13.5B | $15.8K | $5.4B | +14.1% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $4.5M | $5.0B | +2.8% | 3 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $4.4B | $8.0 | $4.9B | +13.5% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.6B | $6.8M | $3.9B | +38.7% | 2 | +0.0% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.2B | $387.9 | $3.1B | -26.7% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $50.7K | $2.0B | +15.8% | 1 | +0.0% |
| HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $44.7K | $1.7B | -15.0% | 1 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $101.9K | $1.7B | -9.8% | 1 | +0.0% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.9B | $21.9M | $1.5B | -28.1% | 1 | +0.6% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $376.4 | $1.4B | -13.5% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $7.6K | $1.2B | -11.7% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $1.7K | $1.0B | -47.2% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $2.1K | $871.2M | +28.2% | 1 | +0.0% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $51.1K | $841.5M | +27.0% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $99.3B calculated opportunity across 19 products.
- Switzerland, Liechtenstein (CHE): $30.4B calculated opportunity across 2 products.
- Netherlands (NLD): $19.2B calculated opportunity across 5 products.
- Germany (DEU): $17.1B calculated opportunity across 8 products.
- Spain (ESP): $10.1B calculated opportunity across 5 products.
- China (CHN): $9.9B calculated opportunity across 3 products.
- Canada (CAN): $9.8B calculated opportunity across 6 products.
- Mexico (MEX): $9.8B calculated opportunity across 5 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- France (FRA): $9.0B calculated opportunity across 5 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- United Kingdom (GBR): $6.1B calculated opportunity across 2 products.

## Growth stars

- HS 382499: +248.0% average CAGR, $15.3B calculated opportunity.
- HS 300215: +88.4% average CAGR, $37.4B calculated opportunity.
- HS 382600: +83.3% average CAGR, $6.2B calculated opportunity.
- HS 293499: +38.7% average CAGR, $3.9B calculated opportunity.
- HS 293339: +28.2% average CAGR, $871.2M calculated opportunity.
- HS 300449: +27.0% average CAGR, $841.5M calculated opportunity.
- HS 300420: +15.8% average CAGR, $2.0B calculated opportunity.
- HS 382200: +14.1% average CAGR, $5.4B calculated opportunity.
- HS 300214: +13.5% average CAGR, $4.9B calculated opportunity.
- HS 330210: +10.2% average CAGR, $9.6B calculated opportunity.

## Diversification opportunities

- HS 300490: 23 buyer markets, $117.6B calculated opportunity.
- HS 382499: 9 buyer markets, $15.3B calculated opportunity.
- HS 300439: 7 buyer markets, $14.4B calculated opportunity.
- HS 300215: 6 buyer markets, $37.4B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 382200: 4 buyer markets, $5.4B calculated opportunity.
- HS 300212: 3 buyer markets, $9.0B calculated opportunity.
- HS 382600: 3 buyer markets, $6.2B calculated opportunity.
- HS 330300: 3 buyer markets, $5.0B calculated opportunity.
- HS 330210: 2 buyer markets, $9.6B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.